Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic review. [electronic resource]
Producer: 20131202Description: 215-28 p. digitalISSN:- 1179-2027
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Cost-Benefit Analysis
- ErbB Receptors -- antagonists & inhibitors
- Genetic Markers
- Genetic Testing -- economics
- Health Care Costs
- Humans
- Mutation
- Neoplasm Metastasis
- Pharmacogenetics
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Treatment Outcome
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.